Pfizer COVID Vaccine Limits Affect Pharmacies Across Canada

Rising Demand Creates Immediate Strain

Canadians seeking COVID-19 vaccinations at local pharmacies are encountering shortages as high demand outpaces supply. The surge comes during the peak of the respiratory illness season, prompting increased community interest in booster doses and updated formulations.

Manufacturer Temporarily Caps Pharmacy Orders

Pfizer Canada confirmed it has placed short-term limits on orders of its 0.3-millilitre pre-filled syringe product used outside hospital settings. According to Sophie Morin, senior manager of external communications, the measure is intended to stabilize distribution while demand remains unusually elevated.

Alternative Formats Remain Accessible

Despite limits on pre-filled syringes, Pfizer says multi-dose vials—commonly used in past vaccination campaigns—continue to be available for pharmacies. These vials offer cost-efficient packaging and storage, though single-dose syringes typically provide rural and small clinics more flexibility in handling and distribution.

Hospital Supplies Unaffected by Constraints

Pfizer emphasized that its 10-pack pre-filled syringes remain available for distributors serving public health programs. Hospital and long-term care facilities continue receiving vaccinations through provincial supply channels, with no reported interruptions.

Provinces Adjust Allocation to Meet Needs

Ontario’s Ministry of Health said the province still has vaccine supply ready for order and distribution. Officials reiterated that public vaccination programs are fully stocked to protect families during respiratory season. However, some regions—such as Calgary—have reported waitlists as pharmacies struggle to secure shipments.

Other Manufacturers Maintain Deliveries

Moderna Canada confirmed it is delivering doses to provinces and territories as scheduled. Provincial and territorial health authorities continue managing the allocation and public rollout of all available COVID-19 vaccines to balance supply across communities.

The post Pfizer COVID Shot Shortage Hits Pharmacies Nationwide first appeared on Maple News Wire.

The updated COVID vaccine and its rollout in Canada are making headlines once again. Infectious disease experts emphasize that this fall’s updated dose is especially important for seniors and high-risk groups. As COVID continues to circulate, doctors warn that the illness still carries real risks, despite many people moving on from pandemic concerns.

“COVID can still be a very serious illness,” explained infectious disease specialist Dr. Isaac Bogoch. He highlighted that while some have placed the virus in the “rear-view mirror,” seniors and immunocompromised individuals remain highly vulnerable.

What’s New About the Updated Vaccine?

Health Canada has authorized updated mRNA vaccines from Pfizer-BioNTech and Moderna for everyone six months and older. Both vaccines directly target the LP.8.1 variant, a descendant of Omicron that global health authorities tracked earlier this year.

Moderna also confirmed that its Canadian doses will be produced in Laval, Quebec, with syringes filled in Cambridge, Ontario. This signals a stronger domestic role in vaccine manufacturing, ensuring smoother access for Canadians.

Why Annual Shots Are the New Normal

Dr. Bogoch compared this shift to the flu vaccine strategy, where updated doses are designed each year to match circulating strains.

“We’ve seen the composition of these vaccines evolve as the virus continues to evolve,” he explained. “This fall’s version should better match the strains spreading in Canada.”

The move shows how public health officials are preparing Canadians for an annual rhythm of vaccination rather than the emergency approach of the early pandemic years.

Who Needs the Vaccine Most?

The National Advisory Committee on Immunization (NACI) has set clear guidance for different groups:

• Two doses per year: Adults 80 and older, long-term care residents, and those six months or older with severe immune conditions.

• One dose per year: Adults aged 65 to 79, health-care workers, and those at increased risk of severe illness.

Distribution plans will be determined by each province and territory, and eligible groups will receive doses free of charge.

Why Seniors and High-Risk Canadians Should Not Skip

While many Canadians may wonder whether they need another dose, Bogoch pointed to clear evidence.

“We can see who is overwhelmingly getting hospitalized and who is dying from this infection,” he said. “It really is people over 65, and especially those over 80.”

The data reveal that seniors and immunocompromised individuals face the highest risks from COVID. That makes the updated vaccine not just a recommendation, but a lifeline.

COVID may not dominate headlines the way it once did, but experts stress the importance of vigilance. With updated vaccines available and domestic manufacturing ramping up, Canada is better positioned to protect its most vulnerable populations.

As Dr. Bogoch noted, treating COVID more like seasonal flu with annual doses may be the best way forward.

Stay tuned to Maple Wire for the next big update in Canadian health news.

The post COVID Vaccine Update: Why Seniors Need It Most This Fall first appeared on Maple News Wire.

COVID-19 is making headlines again, with a fresh variant—NB.1.8.1—causing a rise in cases across parts of the globe. The World Health Organization (WHO) is keeping a close eye on the situation, but here’s what you need to know right now.

Where Are Cases Rising?

The latest data shows that COVID-19 cases are climbing in the eastern Mediterranean, Southeast Asia, and western Pacific regions. Some countries in these areas are also seeing more hospitalizations.

Airport screenings in the United States have already detected the NB.1.8.1 variant in travelers arriving from these regions, with cases popping up in California, Washington, Virginia, and New York.

What Is the NB.1.8.1 Variant?

NB.1.8.1 is the newest COVID-19 variant under monitoring by the WHO. By mid-May, it made up nearly 11% of sequenced cases worldwide. While it’s spreading, there’s good news: the WHO considers the global public health risk to be low, and current vaccines are still expected to work well against it.

Is the New Variant More Dangerous?

So far, there’s no evidence that NB.1.8.1 causes more severe illness than previous versions. The dominant strain in the U.S. and around the world remains LP.8.1, but health officials are watching NB.1.8.1 closely for any changes.

What’s Changing in the U.S.?

In a surprising move, U.S. Health Secretary Robert F. Kennedy Jr. announced that COVID-19 vaccines are no longer recommended for healthy children and pregnant women. Many public health experts have raised concerns about this decision, especially as new variants continue to emerge.

The Bottom Line

COVID-19 is still evolving, and new variants like NB.1.8.1 are reminders to stay informed. While the risk remains low for now, experts recommend keeping up with vaccine guidance and following updates from health authorities.

The post New COVID-19 Variant NB.1.8.1 Drives Global Case Spike first appeared on Maple News Wire.